Gujarat Alkalies & Chemicals Ltd. AI Stock Analysis
Want to see IN:GUJALKALI full AI Analyst Report?
Gujarat Alkalies & Chemicals Ltd. (GUJALKALI) AI Stock Analysis
Gujarat Alkalies & Chemicals Ltd.
(NSE:GUJALKALI)
Financial performance is the dominant factor with mixed growth and recent losses capping the score. Neutral technical signals offer limited support while high valuation multiples constrain the overall rating.
Gujarat Alkalies & Chemicals Ltd. (GUJALKALI) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 43.63B
- Dividend Yield
- 3.00%
- Average Volume (3M)
- 12.45K
- Price to Earnings (P/E)
- 32.7
- Beta (1Y)
- 0.91
- Revenue Growth
- 11.16%
- EPS Growth
- 88398.04%
- Country
- India
- Employees
- 1,370
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Gujarat Alkalies & Chemicals Ltd. Business Overview & Revenue Model
Company Description
Established in 1973 and headquartered in Vadodara, India, Gujarat Alkalies and Chemicals Limited is engaged in the domestic production and sale of an extensive range of chemical products. Its comprehensive portfolio includes essential items such as c...
How the Company Makes Money
The company primarily makes money by manufacturing and selling bulk industrial chemicals, with revenue largely driven by (1) sales of caustic soda (a key chlor-alkali product widely used by multiple process industries), (2) sales of chlorine and chlo...
Gujarat Alkalies & Chemicals Ltd. Financial Statement Overview
Summary
Mixed results with historical revenue growth offset by recent net losses, margin volatility, and declining equity; low debt provides stability in a cyclical industry.
Income Statement
42NeutralBalance Sheet
58NeutralCash Flow
51Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.98B | 43.58B | 40.73B | 37.79B | 45.16B | 36.94B |
| Gross Profit | 9.09B | 6.03B | 12.36B | 6.18B | 30.07B | 22.84B |
| EBITDA | 6.25B | 4.99B | 3.60B | 1.19B | 11.55B | 10.31B |
| Net Income | 663.50M | -24.10M | -651.20M | -2.37B | 4.10B | 5.60B |
Balance Sheet | ||||||
| Total Assets | 0 | 75.33B | 83.43B | 80.23B | 83.35B | 79.77B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 1.89B | 1.53B | 1.79B | 5.02B | 3.20B |
| Total Debt | 0 | 5.75B | 5.61B | 5.44B | 5.97B | 5.94B |
| Total Liabilities | -51.91B | 23.42B | 23.17B | 19.48B | 21.96B | 20.78B |
| Stockholders Equity | 51.91B | 51.91B | 60.26B | 60.76B | 61.39B | 58.99B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 1.48B | 557.40M | -1.65B | 2.77B | -1.74B |
| Operating Cash Flow | 2.98B | 4.06B | 3.81B | 666.16M | 9.60B | 7.35B |
| Investing Cash Flow | -1.18B | -2.28B | -2.64B | -900.00M | -6.61B | -8.05B |
| Financing Cash Flow | -559.70M | -1.50B | -1.45B | -2.77B | -1.40B | 117.44M |
Gujarat Alkalies & Chemicals Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GUJALKALI, the sentiment is Neutral. The current price of 590.20 is above the 20-day moving average (MA) of 572.62, below the 50-day MA of 616.13, and below the 200-day MA of 599.82, indicating a neutral trend. The MACD of -2.34 indicates Negative momentum. The RSI at 50.06 is Neutral, neither overbought nor oversold. The STOCH value of 48.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:GUJALKALI.
Gujarat Alkalies & Chemicals Ltd. Peers Comparison
Overall Rating
IN:GHCL76Outperform
IN:DEEPAKFERT65Neutral
IN:DEEPAKNTR65Neutral
IN:GUJALKALI50Neutral
IN:DCW49Neutral
IN:TATACHEM47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | INR 41.00B | 7.63 | ― | 2.70% | 1.69% | -1.63% | |
| 65Neutral | INR 159.14B | 13.66 | ― | 0.79% | 13.94% | 18.32% | |
| 65Neutral | INR 217.62B | 20.58 | ― | 0.47% | 25.13% | 99.89% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | INR 43.34B | 32.74 | ― | 3.00% | 11.16% | 88398.04% | |
| 49Neutral | INR 14.15B | 20.80 | ― | 0.84% | 15.14% | 35.77% | |
| 47Neutral | INR 154.27B | -6.55 | ― | 1.82% | 4.93% | -1174.55% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:GUJALKALI | Gujarat Alkalies & Chemicals Ltd. | 590.20 | 50.40 | 9.34% | |
| IN:DCW | DCW Ltd. | 47.93 | -22.24 | -31.69% | |
| IN:DEEPAKFERT | Deepak Fertilisers and Petrochemicals Corporation Ltd. | 1260.60 | -173.56 | -12.10% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1595.50 | -126.53 | -7.35% | |
| IN:GHCL | Ghcl Limited | 445.00 | -133.51 | -23.08% | |
| IN:TATACHEM | Tata Chemicals Limited | 605.55 | -216.43 | -26.33% |
Gujarat Alkalies & Chemicals Ltd. Corporate Events
GACL Appoints Dr. Brijesh Patel to Lead Research and Development
Gujarat Alkalies and Chemicals Ltd. is a Gujarat government-promoted chemical manufacturer focused on industrial chemicals and green technology. The company appointed Dr. Brijesh Patel as General Manager and Head of Research and Development, strength...
Gujarat Alkalies and Chemicals Schedules Investor Meeting with HSBC Securities
Gujarat Alkalies and Chemicals Ltd. has notified the stock exchanges that it will hold a virtual one-to-one meeting with HSBC Securities and Capital Markets (India) Pvt. Ltd. on 18 September 2026. The interaction will be part of its ongoing engagemen...
Gujarat Alkalies & Chemicals Updates Investor Presentation on Website
Gujarat Alkalies & Chemicals Ltd. has announced that it has uploaded an updated investor presentation to its corporate website for the benefit of its investors and shareholders. The filing, addressed to both BSE Ltd. and the National Stock Exchange o...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
